Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial. [electronic resource] by
- Awada, Ahmad
- Colomer, Ramon
- Inoue, Kenichi
- Bondarenko, Igor
- Badwe, Rajendra A
- Demetriou, Georgia
- Lee, Soo-Chin
- Mehta, Ajay O
- Kim, Sung-Bae
- Bachelot, Thomas
- Goswami, Chanchal
- Deo, Suryanarayan
- Bose, Ron
- Wong, Alvin
- Xu, Feng
- Yao, Bin
- Bryce, Richard
- Carey, Lisa A
Producer: 20170217
In:
JAMA oncology vol. 2
Availability: No items available.
|